Compound Detail
CHEMBL4852064
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
C[C@H]1[C@@H](OCCN(CCO[C@H]2O[C@@H]3O[C@]4(C)CC[C@H]5[C@H](C)CC[C@@H]([C@H]2C)[C@@]35OO4)CCO[C@H]2O[C@@H]3O[C@]4(C)CC[C@H]5[C@H](C)CC[C@@H]([C@H]2C)[C@@]35OO4)O[C@@H]2O[C@]3(C)CC[C@H]4[C@H](C)CC[C@@H]1[C@@]24OO3
Basic Information
| ChEMBL ID | CHEMBL4852064 |
| Phase | Preclinical |
| Structure Type | MOL |
| InChI Key | WBQLDWVKPMSOFZ-ZNZIVKBUSA-N |
4
Targets
4
Activities
1
Assay Types
0
PK Parameters
4
Publications
0
Known Names
Molecular Properties
948.2
MW (Da)
7.96
ALogP
16
HBA
0
HBD
141.7
PSA (Ų)
0.17
QED
3
Ro5 Violations
12
Rot. Bonds
Drug Information
| Molecule Type | Unknown |
| Availability | Unknown |
| Chirality | Unknown |
Activity Summary
IC50 4 meas. best 8.0
Target Activity Profile
Activity Data Samples
Top measurements by pChEMBL value
| Target | Type | Rel. | Value | Units | pChEMBL | Assay | PubMed |
|---|---|---|---|---|---|---|---|
| K562 | IC50 | = | 10.0 | nM | 8.0 | Anticancer activity against human K562 cells assessed as inhibition of cell prol... | 34399390 |
| HepG2 | IC50 | = | 2510.0 | nM | 5.6 | Anticancer activity against human HepG2 cells assessed as inhibition of cell pro... | 34399390 |
| HeLa | IC50 | = | 5890.0 | nM | 5.23 | Anticancer activity against human HeLa cells assessed as inhibition of cell prol... | 34399390 |
| H322 | IC50 | = | 6610.0 | nM | 5.18 | Anticancer activity against human H322 cells assessed as inhibition of cell prol... | 34399390 |
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 34399390 | 10.1016/j.ejmech.2021.113754 | HeLa | 1 |
| 34399390 | 10.1016/j.ejmech.2021.113754 | K562 | 1 |
| 34399390 | 10.1016/j.ejmech.2021.113754 | HepG2 | 1 |
| 34399390 | 10.1016/j.ejmech.2021.113754 | H322 | 1 |
Data from ChEMBL 36 via Core Engine